欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/2915/001
药品名称Latanoprost Viatris 50 Mikrogramm/ml Augentropfen, Lösung
活性成分
    • Latanoprost 1.5 µg
剂型Eye drops, solution
上市许可持有人Viatris Pharma GmbH Lütticher Str. 5 53842 Troisdorf Germany
参考成员国 - 产品名称Germany (DE)
Latanoprost Pfizer 0,005 % Augentropfen
互认成员国 - 产品名称
    • Denmark (DK)
      Latanoprost Pfizer
    • Belgium (BE)
      Latanoprost Viatris 50 microgram/ml eye drops solution
    • Netherlands (NL)
      Latanoprost Viatris 50 microgram/ml oogdruppels, oplossing
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Latanoprost Pfizer 50 Mikrogramm/ml Augentropfen
    • France (FR)
    • Greece (GR)
    • Finland (FI)
      Latanoprost Pfizer 50 mikrog/ml silmätipat, liuos
许可日期2011/11/22
最近更新日期2025/01/27
药物ATC编码
    • S01EE01 latanoprost
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase